Market News AIOpen the app

KROS stock news · Keros Therapeutics, Inc.

Stories about Keros Therapeutics, Inc. (KROS) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for KROS

Follow Keros Therapeutics, Inc. (KROS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for KROS
Free on the App Store and Google Play, or on the web.
  1. Nov 16, 2026, 4:17 PM ET · Market

    Keros Therapeutics will buy back up to $5 million in its own stock after getting $20 million from Takeda.

    Good for KROS

    Keros approved up to $5 million in share purchases after receiving a $20 million Takeda payment. It expects cash to cover planned costs into 2029, supporting its outlook.